Cargando…
Evaluation of biomarker canine-prostate specific arginine esterase (CPSE) for the diagnosis of benign prostatic hyperplasia
BACKGROUND: Benign prostatic hyperplasia (BPH) is the most common canine prostatic disorder. Although most or even all intact male dogs may develop BPH by 5–8 years of age, many show no clinical signs. Taking into account the non-specific character of clinical and ultrasonographic findings, a new di...
Autores principales: | Pinheiro, Dora, Machado, João, Viegas, Carlos, Baptista, Cláudia, Bastos, Estela, Magalhães, Joana, Pires, Maria A., Cardoso, Luís, Martins-Bessa, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364560/ https://www.ncbi.nlm.nih.gov/pubmed/28335775 http://dx.doi.org/10.1186/s12917-017-0996-5 |
Ejemplares similares
-
Highlights on the Canine Prostatic Specific Esterase (CPSE): A diagnostic and screening tool in veterinary andrology
por: Melandri, Monica, et al.
Publicado: (2020) -
Concentrations of canine prostate specific esterase, CPSE, at baseline are associated with the relative size of the prostate at three-year follow-up
por: Holst, Bodil S., et al.
Publicado: (2021) -
Benign Prostatic Hyperplasia
Publicado: (2015) -
Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015) -
Ejaculation Effect on Canine Prostatic Specific Esterase Serum Concentration
por: Alonge, Salvatore, et al.
Publicado: (2020)